Global Longlife Hospital and R Share Price

Global Longlife Hospital and Research Limited is an India-based company, which is a multi-specialty tertiary care hospital. The Company offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, gastrointestinal (GI) medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include cardiovascular thoracic surgery (CVTS), joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery, ear, nose, and throat (ENT), plastic surgery, trauma center, urology, laparoscopic surgery, gynecology, and more. Its radiology services include mammography, CT scan, ultrasound, endoscopy, and sonography. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.As of 25 May 2026, Global Longlife Hospital and R share price is ₹11.83. The stock opened at ₹12.50, compared to its previous close of ₹12.20. During today's trading session, Global Longlife Hospital and R share price moved in the range of ₹11.80 to ₹12.79, with an average price of ₹12.29 for the day. Looking at its last 52-week, the stock has touched a low of ₹11.80 and a high of ₹12.79.

The market capitalization of Global Longlife Hospital and R is ₹13 Crs and a dividend yield of 0.00%.